| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/07/2023 | 27.58% | RBC Capital | $99 → $94 | Maintains | Outperform |
| 09/14/2023 | 15.36% | Cantor Fitzgerald | $83 → $85 | Maintains | Neutral |
| 07/31/2023 | 34.36% | RBC Capital | $93 → $99 | Maintains | Outperform |
| 07/31/2023 | 28.94% | Credit Suisse | → $95 | Reiterates | Outperform → Outperform |
| 07/12/2023 | 12.65% | Stephens & Co. | → $83 | Reiterates | Equal-Weight → Equal-Weight |
| 06/02/2023 | 12.65% | Stephens & Co. | → $83 | Reiterates | Equal-Weight → Equal-Weight |
| 05/04/2023 | 28.94% | Credit Suisse | $93 → $95 | Maintains | Outperform |
| 04/28/2023 | 28.94% | Credit Suisse | $93 → $95 | Maintains | Outperform |
| 04/27/2023 | 19.44% | Stephens & Co. | → $88 | Reiterates | → Equal-Weight |
| 04/24/2023 | 24.86% | UBS | $96 → $92 | Maintains | Buy |
| 04/20/2023 | -14.5% | Deutsche Bank | $75 → $63 | Downgrades | Hold → Sell |
| 03/06/2023 | 1.79% | Deutsche Bank | $82 → $75 | Maintains | Hold |
| 03/06/2023 | 8.58% | Mizuho | $87 → $80 | Maintains | Neutral |
| 03/01/2023 | 19.44% | Stephens & Co. | $92 → $88 | Maintains | Equal-Weight |
| 02/28/2023 | 24.86% | Stephens & Co. | → $92 | Reiterates | → Equal-Weight |
| 12/12/2022 | 26.22% | RBC Capital | $94 → $93 | Maintains | Outperform |
| 12/12/2022 | 28.94% | Loop Capital | → $95 | Upgrades | Hold → Buy |
| 12/08/2022 | 18.08% | Mizuho | $80 → $87 | Maintains | Neutral |
| 12/08/2022 | 19.44% | Stephens & Co. | $86 → $88 | Maintains | Equal-Weight |
| 11/02/2022 | 16.72% | Stephens & Co. | $85 → $86 | Maintains | Equal-Weight |
| 11/02/2022 | 8.58% | Mizuho | $78 → $80 | Maintains | Neutral |
| 08/26/2022 | 39.79% | SVB Leerink | $95 → $103 | Maintains | Outperform |
| 08/01/2022 | 27.58% | RBC Capital | $84 → $94 | Maintains | Outperform |
| 08/01/2022 | 35.72% | Raymond James | $85 → $100 | Maintains | Strong Buy |
| 07/29/2022 | 5.86% | Mizuho | $69 → $78 | Maintains | Neutral |
| 07/29/2022 | 15.36% | Barclays | $75 → $85 | Maintains | Underweight |
| 07/28/2022 | 22.15% | UBS | $82 → $90 | Maintains | Buy |
| 06/17/2022 | — | Loop Capital | Initiates Coverage On | → Hold | |
| 05/05/2022 | 28.94% | SVB Leerink | $90 → $95 | Maintains | Outperform |
| 05/05/2022 | 15.36% | Raymond James | $80 → $85 | Maintains | Strong Buy |
| 04/08/2022 | 22.15% | SVB Leerink | $80 → $90 | Maintains | Outperform |
| 03/02/2022 | 5.86% | Credit Suisse | $74 → $78 | Maintains | Outperform |
| 03/01/2022 | 8.58% | SVB Leerink | $83 → $80 | Maintains | Outperform |
| 11/01/2021 | -6.35% | Credit Suisse | $68 → $69 | Maintains | Outperform |
| 09/27/2021 | 15.36% | SVB Leerink | → $85 | Initiates Coverage On | → Outperform |
| 09/24/2021 | 9.93% | UBS | → $81 | Initiates Coverage On | → Buy |
| 09/20/2021 | — | Credit Suisse | Upgrades | Neutral → Outperform | |
| 09/10/2021 | 7.22% | Cowen & Co. | → $79 | Initiates Coverage On | → Outperform |
| 08/12/2021 | -6.35% | Barclays | → $69 | Initiates Coverage On | → Underweight |
| 08/04/2021 | -7.71% | Credit Suisse | $60 → $68 | Maintains | Neutral |
| 07/09/2021 | — | Seaport Global | Initiates Coverage On | → Neutral | |
| 05/03/2021 | -18.57% | Credit Suisse | $56 → $60 | Maintains | Neutral |
| 05/03/2021 | -4.99% | Raymond James | $65 → $70 | Maintains | Strong Buy |
| 03/01/2021 | -24% | Credit Suisse | $54 → $56 | Maintains | Neutral |
| 03/01/2021 | -11.78% | Raymond James | $48 → $65 | Maintains | Strong Buy |
| 11/02/2020 | -51.14% | Credit Suisse | $32 → $36 | Maintains | Neutral |
| 11/02/2020 | -52.5% | Mizuho | $31 → $35 | Maintains | Neutral |
| 09/30/2020 | -34.85% | Raymond James | → $48 | Upgrades | Outperform → Strong Buy |
| 08/06/2020 | -56.57% | Credit Suisse | $28 → $32 | Maintains | Neutral |
| 05/07/2020 | -62% | Deutsche Bank | $32 → $28 | Maintains | Hold |
| 05/06/2020 | -59.28% | Baird | $36 → $30 | Maintains | Neutral |
| 05/06/2020 | -62% | Credit Suisse | $33 → $28 | Maintains | Neutral |
| 05/06/2020 | -52.5% | Raymond James | $40 → $35 | Reiterates | → Outperform |
| 01/28/2020 | -51.14% | Stephens & Co. | → $36 | Reinstates | → Equal-Weight |
| 12/11/2019 | -52.5% | Wells Fargo | $37 → $35 | Downgrades | Overweight → Equal-Weight |
| 09/20/2019 | -53.85% | UBS | $29 → $34 | Maintains | Neutral |
| 09/06/2019 | -60.64% | UBS | $30 → $29 | Maintains | Neutral |
| 07/31/2019 | -38.93% | Raymond James | → $45 | Downgrades | Strong Buy → Outperform |
| 05/01/2019 | -51.14% | BMO Capital | $33 → $36 | Maintains | Market Perform |
| 03/04/2019 | -48.43% | Baird | $40 → $38 | Maintains | Neutral |
| 03/04/2019 | -48.43% | Citigroup | $43 → $38 | Maintains | Buy |
| 01/03/2019 | -63.36% | Deutsche Bank | → $27 | Initiates Coverage On | → Hold |
| 11/14/2018 | -41.64% | Citigroup | $46 → $43 | Maintains | Buy |
What is the target price for Acadia Healthcare Co (ACHC)?
The latest price target for Acadia Healthcare Co (NASDAQ: ACHC) was reported by RBC Capital on November 7, 2023. The analyst firm set a price target for $94.00 expecting ACHC to rise to within 12 months (a possible 27.58% upside). 19 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Acadia Healthcare Co (ACHC)?
The latest analyst rating for Acadia Healthcare Co (NASDAQ: ACHC) was provided by RBC Capital, and Acadia Healthcare Co maintained their outperform rating.
When is the next analyst rating going to be posted or updated for Acadia Healthcare Co (ACHC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Acadia Healthcare Co, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Acadia Healthcare Co was filed on November 7, 2023 so you should expect the next rating to be made available sometime around November 7, 2024.
Is the Analyst Rating Acadia Healthcare Co (ACHC) correct?
While ratings are subjective and will change, the latest Acadia Healthcare Co (ACHC) rating was a maintained with a price target of $99.00 to $94.00. The current price Acadia Healthcare Co (ACHC) is trading at is $73.68, which is out of the analyst's predicted range.